Who owns CYTOKINETICS INC?
- CUSIP Number: 23282wac4
Tip: Access positions for across all investors
Analyze quarterly positions in Cytokinetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytokinetics stock
Who bought or sold CYTOKINETICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Balyasny Asset Management | 36M | $61M | 0% | Jun 2026 |
|
| Two Sigma Investments | 16M | $27M | 15% | Jun 2026 |
|
| Lazard Asset Management | 11M | $194k | 0% | Jun 2026 |
|
| Nuveen | 11M | $19M | -20% | Jun 2026 |
|
| Bank of America Corporation | 11M | $18M | 105% | Jun 2026 |
|
| Capstone Investment Advisors | 5.0M | $8.5M | 0% | Jun 2026 |
|
| Mirabaud Asset Management | 4.6M | $8.1B | 100% | Jun 2026 |
|
| Leucadia National Corporation | 4.0M | $6.9M | -26% | Jun 2026 |
|
| Wellington Management Company | 3.8M | $6.5M | -27% | Jun 2026 |
|
| Wolverine Asset Management | 3.3M | $5.7M | 100% | Jun 2026 |
|
| Goldman Sachs Group | 3.2M | $5.4M | 77% | Jun 2026 |
|
| Morgan Stanley | 3.2M | $4.6M | -20% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 2.5M | $4.3M | 0% | Jun 2026 |
|
| FMR | 1.6M | $2.7M | -87% | Jun 2026 |
|
| Context Capital Management | 1.4M | $2.4M | 0% | Jun 2026 |
|
| Advent Capital Management | 346k | $589k | -70% | Jun 2026 |
|
| SSI Investment Management | 308k | $523k | 0% | Jun 2026 |
|
| Jane Street | 254k | $435k | -40% | Jun 2026 |
|
| Bank of New York Mellon | 200k | $325k | 0% | Jun 2026 |
|
| GAMCO Asset Management | 200k | $341k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 170k | $276k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 150k | $244k | 100% | Jun 2026 |
|
| Russell Investments | 140k | $241k | 0% | Jun 2026 |
|
| Barclays | 94k | $160k | 0% | Jun 2026 |
|